Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Hualon Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, China, specializing in the research, development, and large-scale manufacturing of chemical drugs. The company is a prominent manufacturer of anti-infective agents, particularly cephalosporin antibiotics and macrolides, offered in various dosage forms including powder for injection and oral solids. Its manufacturing facilities are GMP-certified and equipped for high-volume production of lyophilized powders, tablets, and capsules. Beyond its core anti-infective portfolio, Hainan Hualon produces a range of treatments for digestive, cardiovascular, and respiratory conditions. The company serves the domestic Chinese market and maintains an active presence in international pharmaceutical exports.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Hualon Pharmaceutical.